Tuberculosis of spleen
ICD-10 A18.85 is a billable code used to indicate a diagnosis of tuberculosis of spleen.
Tuberculosis of the spleen is a rare form of extrapulmonary tuberculosis, which occurs when the Mycobacterium tuberculosis bacteria infect the spleen. This condition can arise from hematogenous spread from a primary pulmonary infection or from direct extension from adjacent structures. Clinically, patients may present with splenomegaly, abdominal pain, fever, and weight loss. Diagnosis typically involves imaging studies such as ultrasound or CT scans, which may reveal splenic lesions, and microbiological tests including sputum cultures or fine-needle aspiration of the spleen. Treatment usually consists of a multi-drug regimen similar to that used for pulmonary tuberculosis, including isoniazid, rifampicin, pyrazinamide, and ethambutol, administered for an extended period. Monitoring for drug resistance is crucial, as resistant strains can complicate treatment. Public health implications are significant, as tuberculosis is a communicable disease; thus, contact tracing and isolation procedures may be necessary to prevent transmission. Regular follow-up is essential to assess treatment efficacy and manage any potential complications.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with unexplained splenomegaly or systemic symptoms.
Awareness of local tuberculosis prevalence and drug resistance patterns.
Comprehensive pulmonary evaluation and history of exposure to tuberculosis.
Patients with a history of pulmonary tuberculosis presenting with abdominal symptoms.
Coordination with infectious disease specialists for management.
Used when a biopsy of the spleen is performed to confirm tuberculosis.
Pathology report must indicate the presence of Mycobacterium tuberculosis.
Infectious disease specialists should ensure accurate reporting of findings.
Common symptoms include abdominal pain, fever, weight loss, and splenomegaly. Patients may also experience systemic symptoms such as night sweats and fatigue.
Diagnosis typically involves imaging studies like ultrasound or CT scans, along with microbiological tests such as sputum cultures or fine-needle aspiration of the spleen.
Treatment usually involves a multi-drug regimen including isoniazid, rifampicin, pyrazinamide, and ethambutol, administered for an extended period.
As a communicable disease, tuberculosis of the spleen requires contact tracing and isolation procedures to prevent transmission, especially in cases of drug-resistant strains.
